CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

181 hedge funds and large institutions have $2.54B invested in Crinetics Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 75 increasing their positions, 58 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+10
Holders Change %
+5.85%
% of All Funds
2.65%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.13%
New
34
Increased
75
Reduced
58
Closed
23
Calls
$22.4M
Puts
$11.9M
Net Calls
+$10.6M
Net Calls Change
+$12.5M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$144M
2
Jennison Associates
2
Jennison Associates
New York
$90.6M
3
Morgan Stanley
3
Morgan Stanley
New York
$46.1M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$27.7M
5
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$86M

Top Sellers

1
O
1
OrbiMed
New York
$59.3M
2
FLSM
2
Frazier Life Sciences Management
California
$14.1M
3
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$122M
5
CC
5
Commodore Capital
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
51
Two Sigma Investments
New York
$6.87M -$7.43M -208,852 -52%
Barclays
52
Barclays
United Kingdom
$6.8M +$2.76M +77,702 +69%
Victory Capital Management
53
Victory Capital Management
Texas
$6.55M +$4.95M +139,117 +309%
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$6.42M -$4.4M -123,625 -41%
TD Asset Management
55
TD Asset Management
Ontario, Canada
$6.28M +$1.32M +37,000 +27%
Invesco
56
Invesco
Georgia
$6.11M -$197K -5,536 -3%
PBM
57
Propel Bio Management
California
$5.87M +$5.87M +165,000 New
WP
58
Woodline Partners
California
$5.34M – – –
BFM
59
Boothbay Fund Management
New York
$5.16M -$794K -22,327 -13%
NLVP
60
New Leaf Venture Partners
New York
$5.02M – – –
UBS Group
61
UBS Group
Switzerland
$4.93M +$2.01M +56,607 +69%
Prudential Financial
62
Prudential Financial
New Jersey
$4.87M +$154K +4,316 +3%
ECM
63
ExodusPoint Capital Management
New York
$4.54M +$3.51M +98,743 +341%
FCM
64
Farallon Capital Management
California
$4.37M -$8.5M -239,000 -66%
PHP
65
Parkman Healthcare Partners
Connecticut
$4.29M +$735K +20,652 +21%
PC
66
Pier Capital
Connecticut
$4.15M +$4.15M +116,603 New
SAM
67
Simplify Asset Management
Nevada
$4.09M – – –
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
$3.81M +$23.5K +661 +0.6%
EI
69
EAM Investors
California
$3.74M +$385K +10,816 +11%
Swiss National Bank
70
Swiss National Bank
Switzerland
$3.71M -$434K -12,200 -10%
Jane Street
71
Jane Street
New York
$3.67M +$3.21M +90,222 +704%
Citigroup
72
Citigroup
New York
$3.64M +$660K +18,539 +22%
Aberdeen Group
73
Aberdeen Group
United Kingdom
$3.6M +$3.6M +101,196 New
LCG
74
Lisanti Capital Growth
New York
$3.57M +$1.79M +50,265 +101%
JPMorgan Chase & Co
75
JPMorgan Chase & Co
New York
$3.31M +$1.38M +38,674 +71%
1 2
3
4 5